Page 47 - Read Online
P. 47

Della Porta et al.                                                                                                                                                     Comparison of p53 and prohibitin expression

           proinflammatory stimuli can be responsible for NFκB   NFκB leads to infected hepatocytes survival and
           activation, which results in protection of hepatocytes   consequent HCV infection persistence. [21]
                          [9]
           from apoptosis.  Moreover, the HCV core protein
           potentiates NFκB activation and chronically activated   In the present study, RelA/p65 nuclear labelling






































                       P53 labeling score                       Cytoplasmic PHB labeling score              Nuclear PHB labeling score














                                             TUNEL labeling (%)











           Figure 2: Comparative expression of P53 (immunohistochemistry, ×200), PHB (immunohistochemistry, ×400) and TUNEL (immunoassay,
           ×200) by NL, HCV, CIR and HCC. A: absence of P53 expression in NL; B: low expression of P53 in HCV; C: minor expression of P53 in CIR; D:
           high nuclear and cytoplasmic expression of P53 in HCC; E: slight cytoplasmic expression of PHB in NL; F: augmented cytoplasmic expression of
           PHB in HCV; G: high cytoplasmic expression of PHB in CIR; H: strong nuclear and cytoplasmic expression of PHB in HCC; I: slight expression
           of apoptosis in NL; J: increased expression of apoptosis in HCV; K: augmented expression of apoptosis in CIR; L: marked expression of
           apoptosis in HCC; (M, N, O) comparison of the P53 (M), cytoplasmic and nuclear PHB (N) and TUNEL (O) labeling scores by NL, HCV, CIR and
                            0
                                          •
           HCC. *P < 0.05 vs. NL;  P < 0.05 vs. HCV;  P < 0.05 vs. CIR. PHB: prohibitin; TUNEL: transferase-mediated dUTP-biotin nick-end labelling;
           NL: normal liver; CIR: cirrhosis; HCV: hepatitis C virus; HCC: hepatocellular carcinoma
                           Hepatoma Research ¦ Volume 3 ¦ February 28, 2017                                39
   42   43   44   45   46   47   48   49   50   51   52